Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gasser

Showing results (251-260 of 476) with videos related to

Pageof 48
Sort By:
Plos One|November 8, 2012
Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementiaWalter Maetzler, Youyong Tian, Stephanie Maria Baur, et al.
Plos One|March 12, 2016
Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding FactorsFelix P Bernhard, Sebastian Heinzel, Gerhard Binder, et al.
Parkinsonism & Related Disorders|March 15, 2016
A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish familyHasmet A Hanagasi, Anamika Giri, Ece Kartal, et al.
Neurobiology of Aging|November 3, 2015
Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variantsCornelis Blauwendraat, Carlo Wilke, Iris E Jansen, et al.
NPJ Parkinson'S Disease|June 13, 2025
Elevated cerebrospinal fluid levels of SERPIN E1 in participants with lewy body diseasesMilan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Experimental Neurology|May 31, 2008
Parkinson patient fibroblasts show increased alpha-synuclein expressionHans-Hermann Hoepken, Suzana Gispert, Mekhman Azizov, et al.
Neurology|June 23, 2012
GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failureKathrin Brockmann, Ruediger Hilker, Ulrich Pilatus, et al.
NPJ Parkinson'S Disease|April 22, 2024
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriersBenjamin Roeben, Inga Liepelt-Scarfone, Stefanie Lerche, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 4, 2011
No evidence for THAP1/DYT6 variants as disease modifiers in DYT1 dystoniaChristoph Kamm, Nils Uflacker, Friedrich Asmus, et al.
Journal of Parkinson'S Disease|September 6, 2024
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's DiseaseMilan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Pageof 48

Showing results (251-260 of 476) with videos related to

Sort By:
Pageof 48
Plos One|November 8, 2012
Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementiaWalter Maetzler, Youyong Tian, Stephanie Maria Baur, et al.
Plos One|March 12, 2016
Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding FactorsFelix P Bernhard, Sebastian Heinzel, Gerhard Binder, et al.
Parkinsonism & Related Disorders|March 15, 2016
A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish familyHasmet A Hanagasi, Anamika Giri, Ece Kartal, et al.
Neurobiology of Aging|November 3, 2015
Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variantsCornelis Blauwendraat, Carlo Wilke, Iris E Jansen, et al.
NPJ Parkinson'S Disease|June 13, 2025
Elevated cerebrospinal fluid levels of SERPIN E1 in participants with lewy body diseasesMilan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Experimental Neurology|May 31, 2008
Parkinson patient fibroblasts show increased alpha-synuclein expressionHans-Hermann Hoepken, Suzana Gispert, Mekhman Azizov, et al.
Neurology|June 23, 2012
GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failureKathrin Brockmann, Ruediger Hilker, Ulrich Pilatus, et al.
NPJ Parkinson'S Disease|April 22, 2024
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriersBenjamin Roeben, Inga Liepelt-Scarfone, Stefanie Lerche, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 4, 2011
No evidence for THAP1/DYT6 variants as disease modifiers in DYT1 dystoniaChristoph Kamm, Nils Uflacker, Friedrich Asmus, et al.
Journal of Parkinson'S Disease|September 6, 2024
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's DiseaseMilan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Pageof 48